Medical Devices & Diagnostics
Medical devices and diagnostics are the hardware of medicine — implants, surgical robots, imaging, and the tests that decide what treatment follows. Approval and reimbursement matter to the investment case as much as the technology does.
342 stocks
| # | Name |
Funds holding | Growth | Growth % |
Fund value |
|
|---|---|---|---|---|---|---|
| 1 |
1
Johnson & Johnson
JNJ
$610B
| 4,661 | +110 | +2% | $432B |
|
| 2 |
2
Abbott
ABT
$181B
| 3,117 | -175 | -5% | $141B |
|
| 3 |
3
Intuitive Surgical
ISRG
$151B
| 2,322 | -98 | -4% | $139B |
|
| 4 |
4
Stryker
SYK
$112B
| 2,312 | -22 | -0.9% | $98.4B |
|
| 5 |
5
Medtronic
MDT
$122B
| 2,252 | -68 | -3% | $95.7B |
|
| 6 |
6
Danaher
DHR
$163B
| 2,184 | -131 | -6% | $108B |
|
| 7 |
7
Boston Scientific
BSX
$64B
| 1,683 | -113 | -6% | $84.2B |
|
| 8 |
8
Becton Dickinson
BDX
$52.8B
| 1,475 | -79 | -5% | $42.1B |
|
| 9 |
9
Edwards Lifesciences
EW
$50.8B
| 1,292 | -23 | -2% | $40.4B |
|
| 10 |
10
GE HealthCare
GEHC
$31.8B
| 1,275 | -64 | -5% | $28.3B |
|
| 11 |
11
DuPont de Nemours
DD
$17.8B
| 1,235 | +12 | +1% | $14.5B |
|
| 12 |
12
Waters Corp
WAT
$43.6B
| 1,178 | +370 | +46% | $29.1B |
|
| 13 |
13
Roper Technologies
ROP
$37.8B
| 1,149 | -115 | -9% | $35.3B |
|
| 14 |
14
Agilent Technologies
A
$49.5B
| 1,075 | -74 | -6% | $28.9B |
|
| 15 |
15
Quest Diagnostics
DGX
$26.4B
| 1,069 | +18 | +2% | $20.1B |
|
| 16 |
16
Labcorp
LH
$26.4B
| 1,037 | +7 | +0.7% | $20.9B |
|
| 17 |
17
DexCom
DXCM
$33.1B
| 962 | +40 | +4% | $23.4B |
|
| 18 |
18
ResMed
RMD
$34.1B
| 945 | -3 | -0.3% | $21.8B |
|
| 19 |
19
Zimmer Biomet
ZBH
$18B
| 918 | -32 | -3% | $17.4B |
|
| 20 |
20
Solventum
SOLV
$15B
| 885 | -58 | -6% | $8.41B |
|
| 21 |
21
Steris
STE
$21.9B
| 846 | -51 | -6% | $20.9B |
|
| 22 |
22
Insulet
PODD
$9.62B
| 788 | -46 | -6% | $14.6B |
|
| 23 |
23
Natera
NTRA
$58.3B
| 767 | -19 | -2% | $26.5B |
|
| 24 |
24
Nordson
NDSN
$18.3B
| 714 | +22 | +3% | $11B |
|
| 25 |
25
DELISTED
Hologic
HOLX
| 705 | -45 | -6% | $16.3B |
|